In addition, ALS patients are characterized by the reduction in NF-L mRNA levels in motor neurons; for this reason, double transgenic animal models knockout for NF-L, and overexpressing peripherin are generated. The gene discussed is PRPH; the disease is amyotrophic lateral sclerosis.